Victoria Hull Sells 2,777 Shares of Hikma Pharmaceuticals PLC (LON:HIK) Stock

Hikma Pharmaceuticals PLC (LON:HIK) insider Victoria Hull sold 2,777 shares of Hikma Pharmaceuticals stock in a transaction on Tuesday, April 8th. The stock was sold at an average price of GBX 1,800 ($23.00), for a total transaction of £49,986 ($63,871.71).

Hikma Pharmaceuticals Price Performance

Shares of LON:HIK opened at GBX 1,774 ($22.67) on Thursday. The company has a debt-to-equity ratio of 55.82, a current ratio of 1.66 and a quick ratio of 1.27. Hikma Pharmaceuticals PLC has a 12 month low of GBX 1,750 ($22.36) and a 12 month high of GBX 2,360 ($30.16). The firm has a market capitalization of £4.92 billion, a P/E ratio of 17.41, a P/E/G ratio of 2.38 and a beta of 0.41. The company’s fifty day moving average price is GBX 2,112.42 and its 200 day moving average price is GBX 2,012.33.

Hikma Pharmaceuticals Increases Dividend

The company also recently announced a dividend, which will be paid on Thursday, May 1st. Stockholders of record on Thursday, March 20th will be issued a $0.48 dividend. This is an increase from Hikma Pharmaceuticals’s previous dividend of $0.32. This represents a dividend yield of 1.8%. The ex-dividend date of this dividend is Thursday, March 20th. Hikma Pharmaceuticals’s payout ratio is presently 60.84%.

Wall Street Analysts Forecast Growth

A number of brokerages have issued reports on HIK. Berenberg Bank reaffirmed a “buy” rating and set a GBX 2,560 ($32.71) price target on shares of Hikma Pharmaceuticals in a report on Monday, March 10th. JPMorgan Chase & Co. restated an “overweight” rating on shares of Hikma Pharmaceuticals in a research note on Friday, March 7th.

About Hikma Pharmaceuticals

At Hikma we help put better health within reach, every day. By creating high-quality medicines and making them accessible to the people who need them, we help to shape a healthier world that enriches all our communities. We help deliver this by living our culture, delivering our strategy, and acting responsibly.